vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与Reservoir Media, Inc.(RSVR)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Reservoir Media, Inc.的1.7倍($75.5M vs $45.6M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 7.7%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $12.8M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 7.9%)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
Reservoir Media是全球领先的独立音乐版权管理企业,拥有并管理海量录音、音乐出版及邻接权版权库,合作各流派知名词曲作者、歌手与制作人,为流媒体平台、影视制作、广告、现场演出等场景提供版权授权服务,业务覆盖北美、欧洲、亚太等主要市场。
PBYI vs RSVR — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$45.6M
营收增速更快
PBYI
高出20.0%
7.7%
自由现金流更多
PBYI
多$1.6M
$12.8M
两年增速更快
PBYI
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $45.6M |
| 净利润 | — | $2.2M |
| 毛利率 | 69.3% | 64.5% |
| 营业利润率 | 22.7% | 22.7% |
| 净利率 | — | 4.8% |
| 营收同比 | 27.7% | 7.7% |
| 净利润同比 | — | -58.1% |
| 每股收益(稀释后) | $0.26 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
RSVR
| Q4 25 | $75.5M | $45.6M | ||
| Q3 25 | $54.5M | $45.4M | ||
| Q2 25 | $52.4M | $37.2M | ||
| Q1 25 | $46.0M | $41.4M | ||
| Q4 24 | $59.1M | $42.3M | ||
| Q3 24 | $80.5M | $40.7M | ||
| Q2 24 | $47.1M | $34.3M | ||
| Q1 24 | $43.8M | $39.1M |
净利润
PBYI
RSVR
| Q4 25 | — | $2.2M | ||
| Q3 25 | $8.8M | $2.3M | ||
| Q2 25 | $5.9M | $-555.7K | ||
| Q1 25 | $3.0M | $2.7M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | $20.3M | $185.0K | ||
| Q2 24 | $-4.5M | $-346.7K | ||
| Q1 24 | $-4.8M | $2.8M |
毛利率
PBYI
RSVR
| Q4 25 | 69.3% | 64.5% | ||
| Q3 25 | 77.7% | 63.6% | ||
| Q2 25 | 76.5% | 64.5% | ||
| Q1 25 | 77.1% | 65.6% | ||
| Q4 24 | 76.4% | 64.4% | ||
| Q3 24 | 63.9% | 63.5% | ||
| Q2 24 | 77.4% | 61.3% | ||
| Q1 24 | 75.5% | 63.4% |
营业利润率
PBYI
RSVR
| Q4 25 | 22.7% | 22.7% | ||
| Q3 25 | 17.6% | 23.5% | ||
| Q2 25 | 12.7% | 14.7% | ||
| Q1 25 | 8.7% | 25.2% | ||
| Q4 24 | 22.6% | 22.6% | ||
| Q3 24 | 27.4% | 24.9% | ||
| Q2 24 | -4.6% | 14.5% | ||
| Q1 24 | -5.3% | 22.4% |
净利率
PBYI
RSVR
| Q4 25 | — | 4.8% | ||
| Q3 25 | 16.2% | 5.0% | ||
| Q2 25 | 11.2% | -1.5% | ||
| Q1 25 | 6.5% | 6.4% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | 25.2% | 0.5% | ||
| Q2 24 | -9.6% | -1.0% | ||
| Q1 24 | -11.0% | 7.1% |
每股收益(稀释后)
PBYI
RSVR
| Q4 25 | $0.26 | $0.03 | ||
| Q3 25 | $0.17 | $0.03 | ||
| Q2 25 | $0.12 | $-0.01 | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | $-0.01 | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $20.6M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $373.6M |
| 总资产 | $216.3M | $941.9M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
RSVR
| Q4 25 | $97.5M | $20.6M | ||
| Q3 25 | $94.4M | $27.9M | ||
| Q2 25 | $96.0M | $14.9M | ||
| Q1 25 | $93.2M | $21.4M | ||
| Q4 24 | $101.0M | $17.8M | ||
| Q3 24 | $96.7M | $21.1M | ||
| Q2 24 | $96.8M | $16.4M | ||
| Q1 24 | $107.2M | $18.1M |
总债务
PBYI
RSVR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益
PBYI
RSVR
| Q4 25 | $130.3M | $373.6M | ||
| Q3 25 | $115.3M | $370.9M | ||
| Q2 25 | $104.7M | $368.9M | ||
| Q1 25 | $97.1M | $364.9M | ||
| Q4 24 | $92.1M | $359.5M | ||
| Q3 24 | $71.1M | $357.9M | ||
| Q2 24 | $48.5M | $353.0M | ||
| Q1 24 | $51.0M | $353.0M |
总资产
PBYI
RSVR
| Q4 25 | $216.3M | $941.9M | ||
| Q3 25 | $202.9M | $903.5M | ||
| Q2 25 | $194.9M | $857.0M | ||
| Q1 25 | $196.2M | $865.1M | ||
| Q4 24 | $213.3M | $832.4M | ||
| Q3 24 | $220.7M | $778.2M | ||
| Q2 24 | $205.0M | $768.2M | ||
| Q1 24 | $214.1M | $783.5M |
负债/权益比
PBYI
RSVR
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $12.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $12.8M |
| 自由现金流率自由现金流/营收 | 19.1% | 28.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 5.89× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $50.1M |
8季度趋势,按日历期对齐
经营现金流
PBYI
RSVR
| Q4 25 | $14.4M | $12.9M | ||
| Q3 25 | $9.7M | $19.3M | ||
| Q2 25 | $14.1M | $6.0M | ||
| Q1 25 | $3.6M | $12.2M | ||
| Q4 24 | $15.6M | $11.2M | ||
| Q3 24 | $11.0M | $13.3M | ||
| Q2 24 | $1.0M | $8.6M | ||
| Q1 24 | $11.2M | $13.8M |
自由现金流
PBYI
RSVR
| Q4 25 | $14.4M | $12.8M | ||
| Q3 25 | $9.7M | $19.2M | ||
| Q2 25 | $14.1M | $6.0M | ||
| Q1 25 | $3.6M | $12.2M | ||
| Q4 24 | $15.6M | $11.2M | ||
| Q3 24 | $11.0M | $13.3M | ||
| Q2 24 | $1.0M | $8.5M | ||
| Q1 24 | — | $13.8M |
自由现金流率
PBYI
RSVR
| Q4 25 | 19.1% | 28.1% | ||
| Q3 25 | 17.7% | 42.2% | ||
| Q2 25 | 26.8% | 16.1% | ||
| Q1 25 | 7.7% | 29.3% | ||
| Q4 24 | 26.4% | 26.5% | ||
| Q3 24 | 13.7% | 32.7% | ||
| Q2 24 | 2.1% | 24.9% | ||
| Q1 24 | — | 35.2% |
资本支出强度
PBYI
RSVR
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率
PBYI
RSVR
| Q4 25 | — | 5.89× | ||
| Q3 25 | 1.10× | 8.54× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | 4.56× | ||
| Q4 24 | — | 2.14× | ||
| Q3 24 | 0.54× | 71.97× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 4.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
RSVR
| Other | $18.9M | 42% |
| Recorded Music Segment | $12.9M | 28% |
| Performance | $6.2M | 14% |
| Synchronization | $4.6M | 10% |
| Physical | $1.9M | 4% |
| Neighboring Rights | $1.1M | 3% |